a year ago
FATE
AnalystsRobert BurnsRobert Burns's Stock Forecasts
AnalystsRobert Burns
Sectors:
Industries:
Analyst Ranking
Bottom 1%
#4582 out of 4587 analysts
Average Return
-11.96%
Win Rate
29%90 out of 313
Risk vs Reward
Poor
Good
Robert Burns's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Adc Therapeutics SaADCT | +477.46% | $0.71 | $4.10 | 2023-11-19 - 2024-05-17 | Buy |
Adc Therapeutics SaADCT | +412.50% | $0.80 | $4.10 | 2023-09-18 - 2024-05-17 | Buy |
Immunomedics IncIMMU | +342.36% | $18.91 | $83.65 | 2020-04-06 - 2020-09-14 | Buy |
Adc Therapeutics SaADCT | +217.83% | $1.29 | $4.10 | 2023-07-24 - 2024-05-17 | Buy |
Turning Point Therapeutics IncTPTX | +208.74% | $35.13 | $108.46 | 2020-03-16 - 2021-03-17 | Buy |
Robert Burns Analyst Color
Get additional color on Robert Burns's coverage of popular stocks
Robert Burns's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Allogene Therapeutics IncALLO | 10 | Buy | $9.00 | +224.91% | Maintains | 5 days ago |
Black Diamond Therapeutics IncBDTX | 6 | Buy | $11.00 | +125.87% | Maintains | 5 days ago |
Pmv Pharmaceuticals IncPMVP | 8 | Buy | $5.00 | +138.10% | Reiterates | 7 days ago |
Caribou Biosciences IncCRBU | 7 | Buy | $24.00 | +607.96% | Reiterates | 7 days ago |
Y Mabs Therapeutics IncYMAB | 9 | Buy | $22.00 | +89.66% | Maintains | 7 days ago |
Macrogenics IncMGNX | 13 | Hold | $4.00 | -8.36% | Maintains | 7 days ago |
Omega Therapeutics IncOMGA | 8 | Buy | $12.00 | +397.93% | Reiterates | 8 days ago |
Cogent Biosciences IncCOGT | 5 | Buy | $19.00 | +155.38% | Reiterates | 8 days ago |
Revolution Medicines IncRVMD | 12 | Buy | $44.00 | +11.65% | Reiterates | 8 days ago |
Tango Therapeutics IncTNGX | 6 | Buy | $17.00 | +126.06% | Reiterates | 12 days ago |
Arrivent Biopharma IncAVBP | 2 | Buy | $25.00 | +24.38% | Reiterates | 12 days ago |
Apollomics IncAPLM | 5 | Buy | $2.00 | +502.41% | Maintains | 12 days ago |
Biontech SeBNTX | 22 | Buy | $113.00 | +24.71% | Maintains | 13 days ago |
Adc Therapeutics SaADCT | 15 | Buy | $8.00 | +95.12% | Maintains | 14 days ago |
Zymeworks IncZYME | 13 | Hold | $10.00 | +9.65% | Reiterates | 14 days ago |
Springworks Therapeutics IncSWTX | 21 | Buy | $74.00 | +65.03% | Reiterates | 15 days ago |
Exelixis IncEXEL | 2 | Buy | $28.00 | +33.91% | Reiterates | 17 days ago |
Kronos Bio IncKRON | 8 | Buy | $2.25 | +120.59% | Maintains | 17 days ago |
Elicio Therapeutics IncELTX | 3 | Buy | $10.00 | -0.50% | Maintains | 20 days ago |
Igm Biosciences IncIGMS | 11 | Hold | $12.00 | +30.15% | Reiterates | a month ago |
Viracta Therapeutics IncVIRX | 8 | Buy | $4.00 | +395.66% | Reiterates | a month ago |
Nuvation Bio IncNUVB | 7 | Buy | $8.00 | +140.96% | Maintains | 2 months ago |
Effector Therapeutics IncEFTR | 3 | Buy | $24.00 | +1,137.11% | Reiterates | 2 months ago |
Calidi Biotherapeutics IncCLDI | 2 | Buy | $2.00 | +777.19% | Maintains | 2 months ago |
Oric Pharmaceuticals IncORIC | 13 | Buy | $21.00 | +129.26% | Maintains | 2 months ago |
Repare Therapeutics IncRPTX | 11 | Buy | $10.00 | +181.69% | Reiterates | 2 months ago |
Prelude Therapeutics IncPRLD | 8 | Hold | $5.00 | +25.00% | Downgrades | 3 months ago |
Nurix Therapeutics IncNRIX | 10 | Buy | $19.00 | +14.53% | Maintains | 3 months ago |
Kineta IncKA | 4 | Buy | $8.00 | +1,669.91% | Reiterates | 4 months ago |
Relay Therapeutics IncRLAY | 12 | Buy | $17.00 | +156.02% | Maintains | 5 months ago |
Portage Biotech IncPRTG | 5 | Buy | $6.00 | +2,243.75% | Maintains | 6 months ago |
Aadi Bioscience IncAADI | 9 | Buy | $36.00 | +1,784.82% | Maintains | 6 months ago |
Replimune Group IncREPL | 8 | Buy | $48.00 | +645.34% | Maintains | 6 months ago |
Kinnate Biopharma IncKNTE | 6 | Buy | $24.00 | +805.66% | Reiterates | 9 months ago |
Gt Biopharma IncGTBP | 6 | Buy | $150.00 | +4,707.69% | Reiterates | 9 months ago |
Atara Biotherapeutics IncATRA | 5 | Buy | $28.00 | +4,490.16% | Maintains | a year ago |
Ikena Oncology IncIKNA | 4 | Buy | $22.00 | N/A | Reiterates | a year ago |
Fate Therapeutics IncFATE | 6 | Hold | $7.00 | N/A | Downgrades | a year ago |
Tcr2 Therapeutics IncTCRR | 4 | Buy | $13.00 | N/A | Maintains | a year ago |
Neurogene IncNGNE | 3 | Hold | N/A | N/A | Downgrades | 2 years ago |
Forma Therapeutics Holdings IncFMTX | 2 | Hold | $20.00 | N/A | Downgrades | 2 years ago |
Turning Point Therapeutics IncTPTX | 6 | Hold | $76.00 | N/A | Downgrades | 2 years ago |
Cytomx Therapeutics IncCTMX | 1 | Buy | $11.00 | N/A | Maintains | 2 years ago |
Nucana PLCNCNA | 7 | Buy | $225.00 | N/A | Maintains | 2 years ago |
Molecular Partners AgMOLN | 1 | Buy | $25.00 | N/A | Assumes | 3 years ago |
Autolus Therapeutics PLCAUTL | 1 | Buy | $13.00 | N/A | Maintains | 3 years ago |
Immunomedics IncIMMU | 4 | Hold | $88.00 | N/A | Downgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.